Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandeep Randhawa

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Molecular Genetics and Metabolism|February 22, 2025
Genetic analysis and multimodal imaging confirm m.12148 T > C mitochondrial variant pathogenicity leading to multisystem dysfunctionKinsley Belle, Alexander Kreymerman, Jill L Young, et al.
Retina (Philadelphia, Pa.)|October 30, 2023
LONG-TERM USE OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONTedi Begaj, Daeun Jeong, Jong G Park, et al.
Ophthalmology. Retina|April 2, 2019
Predictors of Endophthalmitis after Intravitreal Injection: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine StrengthMaxwell S Stem, Prethy Rao, Ivan J Lee, et al.
Retina (Philadelphia, Pa.)|October 20, 2020
CLINICAL OUTCOMES AND TREATMENT COURSE OF EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION FOLLOWING THE DEVELOPMENT OF ENDOPHTHALMITISNicole Koulisis, Stavros N Moysidis, Viren K Govindaraju, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Molecular Genetics and Metabolism|February 22, 2025
Genetic analysis and multimodal imaging confirm m.12148 T > C mitochondrial variant pathogenicity leading to multisystem dysfunctionKinsley Belle, Alexander Kreymerman, Jill L Young, et al.
Retina (Philadelphia, Pa.)|October 30, 2023
LONG-TERM USE OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONTedi Begaj, Daeun Jeong, Jong G Park, et al.
Ophthalmology. Retina|April 2, 2019
Predictors of Endophthalmitis after Intravitreal Injection: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine StrengthMaxwell S Stem, Prethy Rao, Ivan J Lee, et al.
Retina (Philadelphia, Pa.)|October 20, 2020
CLINICAL OUTCOMES AND TREATMENT COURSE OF EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION FOLLOWING THE DEVELOPMENT OF ENDOPHTHALMITISNicole Koulisis, Stavros N Moysidis, Viren K Govindaraju, et al.
Pageof 8